Breaking News Instant updates and real-time market news.

INTC

Intel

$44.91

0.39 (0.88%)

09:02
02/07/18
02/07
09:02
02/07/18
09:02

Intel announces new Intel Xeon D-2100 processor

Intel introduced the new Intel Xeon D-2100 processor, a system-on-chip processor architected to address the needs of edge applications and other data center or network applications constrained by space and power. The Intel Xeon D-2100 processor extends the record-breaking performance and innovation of the Intel Xeon Scalable platform from the heart of the data center to the network edge and web tier, where network operators and cloud service providers face the need to continuously grow performance and capacity without increasing power consumption. Intel Xeon D-2100 processors will enable greater performance and hardware-enhanced security to the network edge in support of the growing number of workloads that demand more compute, analytics and data protection closer to endpoint devices. The new processors will also enable CoSPs to deliver higher-capacity workload-optimized networking services with enhanced performance at lower power in virtual customer premise equipment such as VPNs and encryption services. The Intel Xeon D-2100 processors include up to 18 "Skylake-server" generation Intel Xeon processor cores and integrated Intel QuickAssist Technology with up to 100 Gbps of built-in cryptography, decryption and encryption acceleration. In addition to those data protection enhancements, this product will be supported by system software updates to protect customers from the security exploits referred to as "Spectre" and "Meltdown."

INTC Intel
$44.91

0.39 (0.88%)

01/31/18
BARD
01/31/18
NO CHANGE
BARD
Baird checks show Apple will bring Qorvo in on super PAD
Baird analyst Tristan Gerra say his firm's recent industry checks support the belief Apple (AAPL) will dual source the super PAD in 2018 and bring Qorvo (QRVO) in. Shares of Qorvo are up 37c to $71.04 in midday trading. Apple will have 3.5GHz in the second half of 2018, offering more capacity and benefiting carriers, Gerra tells investors in a research note. He also believes Broadcom (AVGO) is working on custom 802-11.ax for Apple, with Qualcomm (QCOM) being one year behind on .ax. Gerra added that the checks indicate Intel's (INTC) 7560 modem sampling is on track.
01/30/18
01/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CVS Health (CVS) upgraded to Strong Buy from Buy at Needham by analyst Kevin Caliendo, who contended that the stock remains underowned and, unlike its peers, yet to rally beyond the expectations of benefits from the tax changes. The analyst says the company's multiple has remained constant despite the expansion in the rest of the pharma services industry, forecasting EPS growth of 8%-10% beyond the modeled $8 per share in 2019. 2. JetBlue (JBLU) upgraded to Overweight from Neutral at JPMorgan by analyst Jamie Bakier who said the company's costs are "gradually coming under control" and its balance sheet is "sound." The analyst also upgraded United Continental (UAL) to Overweight from Underweight, saying the shares are the "cheapest in the sector and among the most washed out, having declined the most from recent highs." 3. Gilead (GILD) upgraded to Buy from Neutral at Citi by analyst Robyn Karnauskas, who said that tax reform could lower the company's tax rate to 22% in 2018 versus prior estimates of 28%. The analyst also raised her nonalcoholic steatohepatitis and JAK-1 probability of success estimates to 50% with both Phase 3 trials expected in the next 12 months. Further, Karnauskas expects Gilead's hepatitis C virus business to stabilize by mid-2018. 4. Intel (INTC) upgraded to Buy from Neutral at Citi by analyst Christopher Danely, who said overly conservative guidance and poor sentiment from years of underperformance should drive estimates and the stock higher in the near term. He believes management's "new habit" of conservative guidance is good for the stock. 5. Albemarle (ALB) upgraded to Buy from Neutral at UBS by analyst John Roberts, who said the stock is down 23% from the November high despite no change to the outlook for lithium. The analyst attributes the pullback to larger scale lithium expansion announcements and raising concerns of potential oversupply. He believes the market is pricing in 10% annual realized price declines for Albemarle over the next few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/26/18
RHCO
01/26/18
NO CHANGE
Target $50
RHCO
Hold
Intel price target raised to $50 from $43 at SunTrust
SunTrust analyst William Stein raised his price target on Intel to $50 but kept his Hold rating after Q4 earnings, saying the upside seen in the results was a one-off and not likely to recur. Stein says the Data Center Group growth remains "uninspiring" this year, attributing his price target change to more favorable tax rates.
01/26/18
MKMP
01/26/18
NO CHANGE
Target $55
MKMP
Buy
Intel price target raised to $55 from $50 at MKM Partners
MKM Partners analyst Ruben Roy raised his price target on Intel to $55 and kept his Buy rating after Q4 earnings. Roy says the company continues to highlight the data-centric portion of its business as it diversifies away from the PC market, which drive Intel to faster longer-term revenue growth at stronger profitability margins. The analyst expects the multiples to follow, noting that the current valuation appears attractive while raising his FY18 EPS view to $3.55 from $3.25.

TODAY'S FREE FLY STORIES

CNI

Canadian National

$79.75

-1.06 (-1.31%)

05:11
06/22/18
06/22
05:11
06/22/18
05:11
Hot Stocks
Canadian National investing $10M in Nova Scotia rail infrastructure in 2018 »

CN said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

AMRX

Amneal Pharmaceuticals

$17.02

-1.18 (-6.48%)

05:11
06/22/18
06/22
05:11
06/22/18
05:11
Initiation
Amneal Pharmaceuticals initiated  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNA

CareDx

$14.60

-0.145 (-0.98%)

, NTRA

Natera

$14.07

-0.55 (-3.76%)

05:09
06/22/18
06/22
05:09
06/22/18
05:09
Recommendations
CareDx, Natera analyst commentary  »

CareDx should be bought…

CDNA

CareDx

$14.60

-0.145 (-0.98%)

NTRA

Natera

$14.07

-0.55 (-3.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRA

Natera

$14.07

-0.55 (-3.76%)

05:07
06/22/18
06/22
05:07
06/22/18
05:07
Hot Stocks
Natera announces new kidney transplant rejection biomarker »

Natera announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$438.06

-8.23 (-1.84%)

05:00
06/22/18
06/22
05:00
06/22/18
05:00
Recommendations
Abiomed analyst commentary  »

Abiomed price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECL

Ecolab

$141.52

-2.14 (-1.49%)

04:57
06/22/18
06/22
04:57
06/22/18
04:57
Downgrade
Ecolab rating change  »

Ecolab downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
06/22/18
06/22
04:55
06/22/18
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

June PMI Composite Flash…

QGEN

Qiagen

$36.20

-0.23 (-0.63%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Qiagen participates in a conference call with William Blair »

CFO Sachers participates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

04:55
06/22/18
06/22
04:55
06/22/18
04:55
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

June PMI Composite Flash…

AOBC

American Outdoor Brands

$12.80

-0.42 (-3.18%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
American Outdoor Brands management to meet with Wedbush »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

NGVT

Ingevity

$82.89

-0.12 (-0.14%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Ingevity management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

SBUX

Starbucks

$50.62

-1.6 (-3.06%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Starbucks management to meet with Wedbush »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 10

    Jul

AMGN

Amgen

$186.00

-0.51 (-0.27%)

, ARRY

Array BioPharma

$19.56

-0.43 (-2.15%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO World Congress on…

AMGN

Amgen

$186.00

-0.51 (-0.27%)

ARRY

Array BioPharma

$19.56

-0.43 (-2.15%)

BAYRY

Bayer

$0.00

(0.00%)

HALO

Halozyme

$18.59

-0.88 (-4.52%)

INCY

Incyte

$72.47

-0.97 (-1.32%)

LLY

Eli Lilly

$86.07

-0.17 (-0.20%)

MRK

Merck

$61.17

-0.125 (-0.20%)

SHPG

Shire

$162.43

1.81 (1.13%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$39.02

-0.38 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 23

    Jun

  • 28

    Jun

  • 30

    Jun

  • 30

    Jun

  • 10

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 21

    Dec

  • 28

    Jan

  • 22

    Mar

TAC

TransAlta

$4.95

(0.00%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
TransAlta management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

NUVA

NuVasive

$55.48

-1.18 (-2.08%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
NuVasive has a conference call hosted by JPMorgan »

JPMorgan Analyst Marcus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

HUBG

Hub Group

$53.05

-0.8 (-1.49%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Hub Group management to meet with Loop Capital »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

PVAC

Penn Virginia

$79.38

-1.7 (-2.10%)

, ALOG

Analogic

$83.98

0.025 (0.03%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Hot Stocks
Penn Virginia to replace Analogic in S&P 600 at open on June 22 »

Altaris Capital Partners…

PVAC

Penn Virginia

$79.38

-1.7 (-2.10%)

ALOG

Analogic

$83.98

0.025 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$48.68

-1.035 (-2.08%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Fluor management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Macquarie to hold a summit »

Emerging Industries…

INST

Instructure

$45.00

-1.675 (-3.59%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Instructure management to meet with Needham »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

RLH

Red Lion Hotels

$11.70

-0.15 (-1.27%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Red Lion Hotels management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Stephens food/agribusiness analyst to hold an analyst/industry conference call »

Food & Agribusiness…

04:55
06/22/18
06/22
04:55
06/22/18
04:55
General news
Breaking General news story  »

Week of 6/22 Baker-Hughes…

NUVA

NuVasive

$55.48

-1.18 (-2.08%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
NuVasive management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

IRTC

iRhythm

$79.00

-1.67 (-2.07%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
iRhythm management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.